Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Stark

Showing results (431-440 of 453) with videos related to

Pageof 46
Sort By:
European Journal of Pharmacology|January 23, 2023
Adriforant is a functional antagonist of histamine receptor 4 and attenuates itch and skin inflammation in miceÖzge Uluckan, Sandro Bruno, Yichen Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2015
RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complexNicholas G Brown, Ryan VanderLinden, Edmond R Watson, et al.
Nature Methods|August 4, 2015
ProteoPlex: stability optimization of macromolecular complexes by sparse-matrix screening of chemical spaceAshwin Chari, David Haselbach, Jan-Martin Kirves, et al.
Toxins|April 25, 2025
Protocol and Demographics of the RELY-CD Study: Assessing Long-Term Clinical Response to Botulinum Neurotoxin in Cervical DystoniaBenjamin Waeschle, John-Ih Lee, Tristan Kölsche, et al.
ACS Chemical Neuroscience|December 15, 2021
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H<sub>3</sub> and Sigma-1 Receptor Antagonists with Promising Antinociceptive PropertiesKatarzyna Szczepańska, Sabina Podlewska, Maria Dichiara, et al.
Leukemia|May 5, 2022
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathwayM Hanief Sofi, Linlu Tian, Steven Schutt, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2019
Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding siteEdmond R Watson, Christy R R Grace, Wei Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 13, 2024
Discovery of a Small Molecule Activator of Slack (Kcnt1) Potassium Channels That Significantly Reduces Scratching in Mouse Models of Histamine-Independent and Chronic ItchAnnika Balzulat, W Felix Zhu, Cathrin Flauaus, et al.
European Journal of Medicinal Chemistry|February 17, 2022
Novel D<sub>2</sub>/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatmentRadomir Juza, Iveta Vojtechova, Kristyna Stefkova-Mazochova, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Benzophenone Derivatives with Histamine H<sub>3</sub> Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's DiseaseJustyna Godyń, Paula Zaręba, Dorota Stary, et al.
Pageof 46

Showing results (431-440 of 453) with videos related to

Sort By:
Pageof 46
European Journal of Pharmacology|January 23, 2023
Adriforant is a functional antagonist of histamine receptor 4 and attenuates itch and skin inflammation in miceÖzge Uluckan, Sandro Bruno, Yichen Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2015
RING E3 mechanism for ubiquitin ligation to a disordered substrate visualized for human anaphase-promoting complexNicholas G Brown, Ryan VanderLinden, Edmond R Watson, et al.
Nature Methods|August 4, 2015
ProteoPlex: stability optimization of macromolecular complexes by sparse-matrix screening of chemical spaceAshwin Chari, David Haselbach, Jan-Martin Kirves, et al.
Toxins|April 25, 2025
Protocol and Demographics of the RELY-CD Study: Assessing Long-Term Clinical Response to Botulinum Neurotoxin in Cervical DystoniaBenjamin Waeschle, John-Ih Lee, Tristan Kölsche, et al.
ACS Chemical Neuroscience|December 15, 2021
Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H<sub>3</sub> and Sigma-1 Receptor Antagonists with Promising Antinociceptive PropertiesKatarzyna Szczepańska, Sabina Podlewska, Maria Dichiara, et al.
Leukemia|May 5, 2022
Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathwayM Hanief Sofi, Linlu Tian, Steven Schutt, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 28, 2019
Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding siteEdmond R Watson, Christy R R Grace, Wei Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 13, 2024
Discovery of a Small Molecule Activator of Slack (Kcnt1) Potassium Channels That Significantly Reduces Scratching in Mouse Models of Histamine-Independent and Chronic ItchAnnika Balzulat, W Felix Zhu, Cathrin Flauaus, et al.
European Journal of Medicinal Chemistry|February 17, 2022
Novel D<sub>2</sub>/5-HT receptor modulators related to cariprazine with potential implication to schizophrenia treatmentRadomir Juza, Iveta Vojtechova, Kristyna Stefkova-Mazochova, et al.
Molecules (Basel, Switzerland)|January 8, 2023
Benzophenone Derivatives with Histamine H<sub>3</sub> Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's DiseaseJustyna Godyń, Paula Zaręba, Dorota Stary, et al.
Pageof 46